SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Contract

23 Sep 2009 07:00

RNS Number : 4945Z
Sabien Technology Group PLC
23 September 2009
 



 23/09/2009

Sabien Technology Group Plc

("Sabien" or "the Company")

Sabien awarded contract for £56,000

The company is pleased to announce it has been awarded a second contract for  £56,000 to fit M2G at a leading mobile telecommunications operator for sites across the UK. 

Alan O'Brien, CEO Sabien Technology said: "We're delighted that yet again a blue chip company has chosen our M2G technology and we look forward to working together with our client to deliver the project benefits. Sabien and M2G have again delivered".  

For further information:

Sabien Technology Group plc

Alan O'Brien - Chief Executive Officer

Gus Orchard - Finance Director

020 7993 3700

Arbuthnot Securities

Antonio Bossi

020 7012 2000

About Sabien

Sabien was set up in 2004 by Alan O' Brien to commercialise M2G, an energy saving technology which reduces gas consumption used in commercial boilers. In September 2007, Sabien launched M3G which reduces electricity consumption in commercial air-conditioning units. Both M2G and M3G are proven to reduce carbon and energy consumption by up to 35% with typical pay back in less than two years. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTQLLFLKKBLBBE
Date   Source Headline
15th Mar 20182:42 pmRNSDirector/PDMR Shareholding
28th Feb 20185:34 pmRNSDirector/PDMR Shareholding
28th Feb 20185:32 pmRNSDirector Loan
14th Feb 20182:59 pmRNSResult of General Meeting
5th Feb 20184:22 pmRNSDirector/PDMR Shareholding
31st Jan 201812:33 pmRNSUnaudited Interim Results to 31 December 2017
19th Jan 20185:10 pmRNSNotice of General Meeting
29th Dec 201711:21 amRNSResult of AGM
7th Dec 20173:10 pmRNSNotice of AGM
7th Dec 20177:00 amRNSAudited Annual Report
1st Aug 20177:00 amRNSChange of Adviser
30th Jun 20177:01 amRNSFinance Director Retirement
30th Jun 20177:00 amRNSOrder Received
20th Apr 20174:45 pmRNSHolding(s) in Company
20th Apr 20174:03 pmRNSHolding(s) in Company
20th Apr 201711:15 amRNSHolding(s) in Company
20th Apr 201711:13 amRNSHolding(s) in Company
20th Apr 201711:11 amRNSHolding(s) in Company
18th Apr 20174:56 pmRNSTotal Voting Rights
18th Apr 201711:51 amRNSResult of GM
29th Mar 201710:00 amRNSNotice of GM
29th Mar 20177:30 amRNSResults of Placing
29th Mar 20177:00 amRNSHalf-year Report
30th Dec 201610:05 amRNSHolding(s) in Company
29th Nov 201612:19 pmRNSResult of AGM
29th Nov 201610:41 amRNSAGM Statement
7th Nov 20165:28 pmRNSNotice of AGM
25th Oct 20167:00 amRNSFinal Results
29th Sep 20163:25 pmRNSHolding(s) in Company
22nd Sep 20164:56 pmRNSHolding(s) in Company
22nd Sep 20164:54 pmRNSHolding(s) in Company
22nd Sep 20164:48 pmRNSHolding(s) in Company
16th Sep 20167:00 amRNS£750,000 Placing To Continue Growth Strategy
13th Jul 201610:47 amRNSResult of Meeting
13th Jul 20169:08 amRNSGM Statement
27th Jun 20169:42 amRNSNotice of GM
2nd Jun 20167:00 amRNSTrading Statement
3rd May 20167:00 amRNSUpdate on pilot programme
9th Feb 20167:00 amRNSHalf Yearly Report
6th Jan 20169:44 amRNSChange of name of Nominated Adviser and Broker
18th Nov 20153:33 pmRNSResult of AGM
18th Nov 201511:08 amRNSAGM Statement
26th Oct 201512:39 pmRNSDespatch of Annual Report and Notice of AGM
23rd Oct 20158:36 amRNSDirectorate Change
8th Oct 20159:39 amRNSDirector/PDMR Shareholding
7th Oct 20157:00 amRNSFinal Results
30th Sep 20156:16 pmRNSAppointment of Director
4th Aug 20155:05 pmRNSHolding(s) in Company
4th Aug 20153:03 pmRNSHolding(s) in Company
3rd Aug 20152:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.